The average Watson Pharmaceuticals Investor Relations earns an estimated $64,350 annually. Watson Pharmaceuticals' Investor Relations compensation is $17,581 less than the US average for a Investor Relations.
Last updated 5 years ago.
The majority of Investor Relations at Watson Pharmaceuticals believe they're compensated fairly. 100% of Investor Relations at Watson Pharmaceuticals say they receive annual bonuses. See more compensation ratings at Watson Pharmaceuticals